2023-508982-34-00CompletedPhase 1
MK-7480 Multiple Ascending Dose Study in Healthy Participants
Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Mar 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- First submitted
- 12 Dec 2023
- Start date
- Feb 2024
- Lead sponsor
- Merck Sharp & Dohme LLC
- EU CT number
- 2023-508982-34-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 44
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.